RESUMEN
BACKGROUND: Glycyl-tRNA synthetase (GARS) is an aminoacyl-tRNA synthetase (ARS) that links the amino acid glycine to its corresponding tRNA prior to protein translation and is one of three bifunctional ARS that are active within both the cytoplasm and mitochondria. Dominant mutations in GARS cause rare forms of Charcot-Marie-Tooth disease and distal spinal muscular atrophy. CASE PRESENTATION: We report a 12-year old girl who presented with clinical and biochemical features of a systemic mitochondrial disease including exercise-induced myalgia, non-compaction cardiomyopathy, persistent elevation of blood lactate and alanine and MRI evidence of mild periventricular leukomalacia. Using exome sequencing she was found to harbor compound heterozygous mutations within the glycyl-tRNA synthetase (GARS) gene; c.1904C > T; p.Ser635Leu and c.1787G > A; p.Arg596Gln. Each mutation occurred at a highly conserved site within the anticodon binding domain. CONCLUSION: Our findings suggest that recessive mutations in GARS may cause systemic mitochondrial disease. This phenotype is distinct from patients with previously reported dominant mutations in this gene, thereby expanding the spectrum of disease associated with GARS dysregulation.
Asunto(s)
Glicina-ARNt Ligasa/genética , Leucomalacia Periventricular/diagnóstico , Enfermedades Mitocondriales/diagnóstico , Mutación Missense , Mialgia/diagnóstico , Secuencia de Aminoácidos , Secuencia de Bases , Niño , Análisis Mutacional de ADN , Tolerancia al Ejercicio/genética , Femenino , Heterocigoto , Humanos , Leucomalacia Periventricular/enzimología , Leucomalacia Periventricular/genética , Enfermedades Mitocondriales/enzimología , Enfermedades Mitocondriales/genética , Técnicas de Diagnóstico Molecular , Mialgia/enzimología , Mialgia/genética , LinajeRESUMEN
Oxidative stress involving premyelinating oligodendrocytes (OLs) is a major factor in the pathogenesis of preterm white matter injury. In animal and cell culture studies, activation of the lipid-oxidizing enzyme 12/15-lipoxygenase (12/15-LOX) plays a central role as an inflammatory mediator in the pathology of oxidative stress and OL cell death, as well as ischemia and neuronal death. The role of 12/15-LOX, however, is unclear in the developing human brain. The mechanism of 12/15-LOX involves the production of reactive oxygen species through the metabolism of arachidonic acid, as well as direct detrimental effects on organelle membranes. Here we tested the hypothesis that the density of 12/15-LOX-expressing cells is increased in periventricular leukomalacia (PVL). Using immunocytochemistry (ICC) in human paraffin-embedded tissue, 12/15-LOX expression was seen in macrophages of the focally necrotic lesions in the periventricular white matter, as well as in glial cells throughout the surrounding white matter with reactive gliosis. Interestingly, no significant 12/15-LOX expression was detected in neurons in the cerebral cortex overlying the damaged white matter. Using a scoring system from 0 to 3, we assessed the density of 12/15-LOX-expressing cells in diffusely gliotic white matter from 20 to 43 postconceptional (PC) weeks in 19 PVL cases (median = 36 PC weeks) and 10 control (non-PVL) cases (median = 34 PC weeks). The density of 12/15-LOX-positive cells was significantly increased in the diffuse component of PVL (score = 1.17 ± 0.15) compared to controls (score = 0.48 ± 0.21; p = 0.014). Using double-label ICC, 12/15-LOX was observed in PVL in OLs of the O4 and O1 premyelinating stages, as well as in mature OLs as determined with the mature OL marker adenomatous polyposis coli (APC). In addition, 12/15-LOX expression was present in a population of CD68-positive activated microglia. There was no 12/15-LOX expression in reactive astrocytes. Finally we observed terminal deoxynucleotide transferase dUTP nick end-labeling-positive cells within the white matter of PVL that expressed 12/15-LOX and/or within close proximity of 12/15-LOX-positive cells. Our data support a role for 12/15-LOX activation as an inflammatory mediator of injury in PVL, with a contribution of 12/15-LOX to PVL-induced damage to or cell death of OLs, including those at the O1 and O4 stages.
Asunto(s)
Araquidonato 12-Lipooxigenasa/biosíntesis , Araquidonato 15-Lipooxigenasa/biosíntesis , Leucomalacia Periventricular/enzimología , Microglía/enzimología , Oligodendroglía/enzimología , Araquidonato 12-Lipooxigenasa/análisis , Araquidonato 15-Lipooxigenasa/análisis , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Recién Nacido , Leucomalacia Periventricular/patologíaRESUMEN
Research into neonatal ischemic brain damage is impeded by the lack of a complete understanding of the initial hemodynamic mechanisms resulting in a lesion, particularly that of NO-mediated vascular mechanisms. In a neonatal stroke rat model, we recently show that collateral recruitment contributes to infarct size variability. Non-specific and selective NO synthase (NOS) inhibition was evaluated on cerebral blood-flow changes and outcome in a P7 rat model of arterial occlusion (left middle cerebral artery electrocoagulation with 50 min occlusion of both common carotid arteries). Blood-flow changes were measured by using ultrasound imaging with sequential Doppler recordings in both internal carotid arteries and basilar trunk. Cortical perfusion was measured by using laser Doppler flowmetry. We showed that global NOS inhibition significantly reduced collateral support and cortical perfusion (collateral failure), and worsened the ischemic injury in both gender. Conversely, endothelial NOS inhibition increased blood-flows and aggravated volume lesion in males, whereas in females blood-flows did not change and infarct lesion was significantly reduced. These changes were associated with decreased phosphorylation of neuronal NOS at Ser(847) in males and increased phosphorylation in females at 24h, respectively. Neuronal NOS inhibition also increased blood-flows in males but not in females, and did not significantly change infarct volumes compared to their respective PBS-treated controls. In conclusion, both nNOS and eNOS appear to play a key role in modulating arterial blood flow during ischemia mainly in male pups with subsequent modifications in infarct lesion.
Asunto(s)
Infarto Encefálico/enzimología , Circulación Cerebrovascular/fisiología , Hipoxia-Isquemia Encefálica/enzimología , Leucomalacia Periventricular/enzimología , Óxido Nítrico Sintasa de Tipo III/fisiología , Óxido Nítrico Sintasa de Tipo I/fisiología , Animales , Animales Recién Nacidos , Infarto Encefálico/patología , Infarto Encefálico/fisiopatología , Circulación Cerebrovascular/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Humanos , Hipoxia-Isquemia Encefálica/patología , Hipoxia-Isquemia Encefálica/fisiopatología , Recién Nacido , Leucomalacia Periventricular/patología , Leucomalacia Periventricular/fisiopatología , Masculino , Óxido Nítrico Sintasa de Tipo I/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo I/química , Óxido Nítrico Sintasa de Tipo III/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo III/química , Ratas , Ratas WistarRESUMEN
Periventricular leukomalacia (PVL) is a lesion of the immature cerebral white matter in the perinatal period and associated predominantly with prematurity and cerebral ischemia/reperfusion as well as inflammation due to maternofetal infection. It consists of focal necrosis in the periventricular region and diffuse gliosis with microglial activation and premyelinating oligodendrocyte (pre-OL) injury in the surrounding white matter. We previously showed nitrotyrosine in pre-OLs in PVL, suggesting involvement of nitrosative stress in this disorder. Here we hypothesize that inducible nitric oxide synthase (iNOS) expression is increased in PVL relative to controls. Using immunocytochemistry in human archival tissue, the density of iNOS-expressing cells was determined in the cerebral white matter of 15 PVL cases [29-51 postconceptional (PC) weeks] and 16 control cases (20-144 PC weeks). Using a standardization score of 0-3, the density of iNOS-positive cells was significantly increased in the diffuse component of PVL (score of 1.8 +/- 0.3) cases compared to controls (score of 0.7 +/- 0.3) (P = 0.01). Intense iNOS expression occurred in reactive astrocytes in acute through chronic stages and in activated microglia primarily in the acute stage, suggesting an early role for microglial iNOS in PVL's pathogenesis. This study supports an important role for iNOS-induced nitrosative stress in the reactive/inflammatory component of PVL.
Asunto(s)
Leucomalacia Periventricular/enzimología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Oligodendroglía/enzimología , Astrocitos/enzimología , Astrocitos/patología , Encéfalo/enzimología , Encéfalo/patología , Femenino , Feto , Humanos , Inmunohistoquímica , Lactante , Recién Nacido , Leucomalacia Periventricular/patología , Masculino , Microglía/enzimología , Microglía/patología , Oligodendroglía/patologíaRESUMEN
Intrauterine inflammation has been implicated in developmental brain injuries, including the development of periventricular leukomalacia (PVL) and cerebral palsy (CP). Previous studies in our rat model of intrauterine inflammation demonstrated apoptotic cell death in fetal brains within the first 5 days after lipopolysaccharide (LPS) administration to mothers and eventual dysmyelination. Cysteine-containing, aspartate-specific proteases, or caspases, are proteins involved with apoptosis through both intracellular (intrinsic pathway) and extracellular (extrinsic pathway) mechanisms. We hypothesized that cell death in our model would occur mainly via activation of the extrinsic pathway. We further hypothesized that Fas, a member of the tumor necrosis factor receptor (TNFR) superfamily, would be increased and the death inducing signaling complex (DISC) would be detectable. Pregnant rats were injected intracervically with LPS at E15 and immunoblotting, immunohistochemical and immunoprecipitation analyses were performed. The presence of the activated form of the effector caspase (caspase-3) was observed 24 h after LPS administration. Caspase activity assays demonstrated rapid increases in (i) caspases-9 and -10 within 1 h, (ii) caspase-8 at 2 h and (iii) caspase-3 at 4 h. At 24 h after LPS, activated caspase-3(+)/Fas(+) cells were observed within the developing white matter. Lastly, the DISC complex (caspase-8, Fas and Fas-associated death domain (FADD)) was observed within 30 min by immunoprecipitation. Apoptosis in our model occurs via both extrinsic and intrinsic pathways, and activation of Fas may play a role. Understanding the mechanisms of cell death in models of intrauterine inflammation may affect development of future strategies to mitigate these injuries in children.
Asunto(s)
Apoptosis , Caspasas/metabolismo , Encefalitis/enzimología , Enfermedades Fetales/enzimología , Degeneración Nerviosa/enzimología , Receptor fas/metabolismo , Animales , Parálisis Cerebral/enzimología , Parálisis Cerebral/etiología , Parálisis Cerebral/fisiopatología , Proteínas Adaptadoras de Señalización del Receptor del Dominio de Muerte/metabolismo , Modelos Animales de Enfermedad , Encefalitis/inducido químicamente , Encefalitis/patología , Activación Enzimática , Proteína de Dominio de Muerte Asociada a Fas/metabolismo , Femenino , Enfermedades Fetales/inducido químicamente , Enfermedades Fetales/patología , Humanos , Recién Nacido , Mediadores de Inflamación , Isoenzimas/metabolismo , Leucomalacia Periventricular/enzimología , Leucomalacia Periventricular/etiología , Leucomalacia Periventricular/fisiopatología , Lipopolisacáridos , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/etiología , Embarazo , Ratas , Transducción de SeñalRESUMEN
Periventricular leukomalacia (PVL) involves free radical injury to developing oligodendrocytes (OLs), resulting from ischemia/reperfusion, particularly between 24 and 32 gestational weeks. Using immunocytochemistry and Western blots, we tested the hypothesis that this vulnerability to free radical toxicity results, in part, from developmental lack of superoxide dismutases (SOD)-1 and -2, catalase, and glutathione peroxidase (GPx) in the telencephalic white matter of the human fetus. During the period of greatest PVL risk and through term (> or = 37 weeks), expression of both SODs (for conversion of O2- to H2O2) significantly lagged behind that of catalase and GPx (for breakdown of H2O2), which, in contrast, superseded adult levels by 30 gestational weeks. Our data indicate that a developmental "mismatch" in the sequential antioxidant enzyme cascade likely contributes to the vulnerability to free radical toxicity of the immature cerebral white matter, which is "unprepared" for the transition from a hypoxic intrauterine to an oxygen-rich postnatal environment. All enzymes, localized to astrocytes and OLs, had higher-than-adult expression at 2 to 5 postnatal months (peak of myelin sheath synthesis), suggesting an adaptive mechanism to protect against lipid peroxidation during myelin sheath (lipid) synthesis. The previously unrecognized dissociation between the expression of the SODs and that of catalase and GPx in the fetal period has potential implications for future antioxidant therapy in PVL.
Asunto(s)
Parálisis Cerebral/enzimología , Leucomalacia Periventricular/enzimología , Fibras Nerviosas Mielínicas/enzimología , Daño por Reperfusión/enzimología , Superóxido Dismutasa/metabolismo , Telencéfalo/enzimología , Anciano , Antioxidantes/metabolismo , Astrocitos/enzimología , Catalasa/metabolismo , Parálisis Cerebral/etiología , Parálisis Cerebral/prevención & control , Preescolar , Femenino , Radicales Libres/metabolismo , Glutatión Peroxidasa/metabolismo , Humanos , Inmunidad Innata/fisiología , Lactante , Recién Nacido , Leucomalacia Periventricular/etiología , Leucomalacia Periventricular/fisiopatología , Peroxidación de Lípido/fisiología , Persona de Mediana Edad , Vaina de Mielina/enzimología , Fibras Nerviosas Mielínicas/patología , Trabajo de Parto Prematuro/complicaciones , Oligodendroglía/enzimología , Estrés Oxidativo/fisiología , Embarazo , Daño por Reperfusión/etiología , Daño por Reperfusión/fisiopatología , Telencéfalo/embriología , Telencéfalo/crecimiento & desarrolloRESUMEN
Oligodendrocyte cultures were used to study the toxic effects of catecholamines. Our results showed that catecholamine-induced toxicity was dependent on the dose of dopamine or norepinephrine used and on the developmental stage of the cultures, with oligodendrocyte progenitors being more vulnerable. A role for oxidative stress and apoptosis on the mechanism of action of catecholamines on oligodendrocyte cell death was next assessed. Catecholamines caused a reduction in intracellular glutathione levels, an accumulation in reactive oxygen species and in heme oxygenase-1, the 32 kDa stress-induced protein. All these changes were prevented by N-acetyl-L-cysteine, a thiocompound with antioxidant activity and a precursor of glutathione, and were more pronounced in progenitors than mature cells, which could contribute to their higher susceptibility. Apoptotic cell death, as assessed by activation of caspase-9 and -3 and cleavage of poly(ADP-ribose) polymerase (a substrate of caspase-3), was only observed in oligodendrocyte progenitors. Pretreatment with zVAD, a general caspase inhibitor, prevented activation of caspase-9 and -3, DNA fragmentation, and decreased progenitors cell death. Furthermore, the expression levels of procaspase-3 and the ratio of the proapoptotic protein bax to antiapoptotic protein bcl-xl were several folds higher in immature than mature oligodendrocytes. Taken together, these results strongly suggest that the catecholamine-induced cytotoxicity in oligodendrocytes is developmentally regulated, mediated by oxidative stress, and have characteristics of apoptosis in progenitor cells.
Asunto(s)
Apoptosis/fisiología , Encéfalo/crecimiento & desarrollo , Catecolaminas/toxicidad , Diferenciación Celular/fisiología , Oligodendroglía/enzimología , Estrés Oxidativo/fisiología , Células Madre/enzimología , Acetilcisteína/metabolismo , Acetilcisteína/farmacología , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Asfixia Neonatal/enzimología , Asfixia Neonatal/fisiopatología , Encéfalo/enzimología , Encéfalo/fisiopatología , Caspasa 3 , Caspasas/metabolismo , Catecolaminas/metabolismo , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Inhibidores Enzimáticos/farmacología , Radicales Libres/metabolismo , Genes bcl-2/genética , Glutatión/metabolismo , Hemo Oxigenasa (Desciclizante)/metabolismo , Hemo-Oxigenasa 1 , Humanos , Recién Nacido , Leucomalacia Periventricular/enzimología , Leucomalacia Periventricular/etiología , Leucomalacia Periventricular/fisiopatología , Proteínas de la Membrana , Oligodendroglía/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Poli(ADP-Ribosa) Polimerasas/metabolismo , Ratas , Ratas Sprague-Dawley , Células Madre/efectos de los fármacosRESUMEN
Estimations of serum enzyme values are widely employed as valuable diagnostic aids in diseases. Most commonly employed enzymes include Aspartate aminotransferase (AST), Lactate dehydrogenase (LDH), and Creatine kinase (CK). The study was designed to determine the relationship of elevated postnatal serum LDH, CK, and AST concentrations within the first day of life and the risk of suffering severe intraventricular hemorrhage (IVH) and/or periventricular leukomalacia (PVL) in VLBW preterm newborns. 81 preterm neonates whose birth body weight < 1500 gm were enrolled. Serums were obtained for measurement within the first postnatal day. Cranial ultrasound scans were performed twice per week after birth until their body weight was above 2300 gm or postconceptional age above 40 weeks. Significant difference was noted in serum LDH and CK concentrations in severe IVH/PVL infants (p < 0.05). No difference was found in serum AST values. Compared with the cut-off values of 1933 IU/L of LDH concentration and 652 IU/L of CK, the predictive values revealed a sensitivity, specificity, negative predictive value and positive predictive value of 76.9%, 89.7%, 95.3% and 58.8%, respectively. In conclusion, higher serum LDH and/or CK concentrations within the first day of life were associated with risk for development of severe IVH/PVL.
Asunto(s)
Hemorragia Cerebral/diagnóstico , Ventrículos Cerebrales , Enzimas/sangre , Enfermedades del Prematuro/diagnóstico , Recién Nacido de muy Bajo Peso , Leucomalacia Periventricular/diagnóstico , Aspartato Aminotransferasas/sangre , Hemorragia Cerebral/enzimología , Creatina Quinasa/sangre , Humanos , Recién Nacido , Enfermedades del Prematuro/enzimología , L-Lactato Deshidrogenasa/sangre , Leucomalacia Periventricular/enzimología , Valor Predictivo de las Pruebas , PronósticoRESUMEN
The incidence of periventricular leukomalacia (PVL) was investigated by ultrasound in a group of 119 consecutively scanned low-birth-weight infants during a period of 3 years. The overall incidence of PVL was 6.7% while the incidence of peri-intraventricular hemorrhage was 44.5%. Ultrasound evidence of posthemorrhagic lesions was seen early and related strongly to follow-up findings. Evidence of cystic degeneration appeared later. The presence of PVL was confirmed by computed tomography at 5 months of age and anticipated by serial measurements of creatine kinase brain isoenzyme performed in the first 60 h of life. A significant correlation was observed between neurosonographic findings of PVL and high cord blood values of enzymatic pattern (p less than 0.02). Both were correlated with poor neurodevelopmental outcome at 12 months corrected age.